These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres. Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737 [TBL] [Abstract][Full Text] [Related]
11. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues. Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459 [TBL] [Abstract][Full Text] [Related]
12. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227 [TBL] [Abstract][Full Text] [Related]
13. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. Herrlinger KR; Barthel DN; Schmidt KJ; Büning J; Barthel CS; Wehkamp J; Stange EF; Fellermann K Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date. Thukral C; Cheifetz A; Peppercorn MA Drugs; 2006; 66(16):2059-65. PubMed ID: 17112300 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review. Wu B; Tong J; Ran Z Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor-α inhibitor. Suzuki T; Mizoshita T; Tanida S; Sugimura N; Katano T; Nishie H; Kataoka H JGH Open; 2019 Jun; 3(3):217-223. PubMed ID: 31276039 [TBL] [Abstract][Full Text] [Related]
18. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy. Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669 [TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Lawson MM; Thomas AG; Akobeng AK Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]